Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 5/20 | 0.42 |
| ▸ | F2 | P00734 | 2/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.34 |
| ▸ | CTSS | P25774 | 5/20 | 0.34 |
| ▸ | CTSK | P43235 | 5/20 | 0.34 |
| ▸ | CTSV | O60911 | 1/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | ENPP2 | Q13822 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | TACR2 | P21452 | 1/20 | 0.31 |
| ▸ | TACR3 | P29371 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3448981 | 0.88 | F10 (0.40) | F10F2CTSL | |
| SCHEMBL3449605 | 0.85 | F10 (0.45) | F10F2CCR1 | |
| SCHEMBL6014942 | 0.84 | F10 (0.49) | F10F2CCR1CHRM3CTSS | |
| SCHEMBL3449086 | 0.84 | F10 (0.46) | F10F2CCR1 | |
| SCHEMBL3448658 | 0.84 | F10 (0.41) | F10F2CTSL | |
| SCHEMBL3451025 | 0.83 | F10 (0.40) | F10F2CHRM3 | |
| SCHEMBL6015040 | 0.82 | F10 (0.45) | F10F2CCR1 | |
| SCHEMBL3448695 | 0.81 | F10 (0.40) | F10F2ENPP2 | |
| SCHEMBL6015054 | 0.81 | F10 (0.44) | F10F2CCR1 | |
| SCHEMBL3451874 | 0.80 | F10 (0.47) | F10F2CCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1695961-A1 | UREA DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE | Takeda Pharmaceutical Company Limited (JP) | 2006-08-30 | — | — | EP | disclosed |